EVERY urges court to sanction Onego Bio as alt protein IP fight turns nasty

The EVERY Company has escalated its legal battle against Onego Bio by filing a motion for sanctions in a Delaware court, accusing Onego of engaging in improper and duplicative litigation based on false claims. In response, Onego Bio asserts that evidence contradicts the statements made by EVERY executives, highlighting the contentious nature of the dispute in the alternative protein sector. This legal confrontation raises significant questions about intellectual property practices within the rapidly evolving alt protein industry.